EMD-38616

Single-particle
3.55 Å
EMD-38616
3D View Gallery
Deposition: 09/01/2024
Map released: 12/02/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-38616

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8xsd summary report (pdf.gz) Map-8xsd FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BA.5 Spike complex with CR9

EMD-38616

Single-particle
3.55 Å
EMD-38616
3D View Gallery
Deposition: 09/01/2024
Map released: 12/02/2025
Last modified: 02/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: RBD in complex with ACE2
Fitted models: 8xsd

Deposition Authors: Feng LL
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.
Chen Z, Feng L, Wang L, Zhang L, Zheng B, Fu H, Li F, Liu L, Lv Q, Deng R, Xu Y, Hu Y, Zheng J, Qin C, Bao L , Wang X , Jin Q
(2025) Signal Transduct Target Ther , 10 , 14 - 14
PUBMED: 39800731
DOI: doi:10.1038/s41392-024-02114-6
ISSN: 2059-3635
Grant Support: